Latest Breaking News On - Therapeutics trading down - Page 13 : vimarsana.com

Deep Track Capital, Lp Sells 56,000 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

Deep Track Capital, Lp Sells 56,000 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesWilliam blairBarclays plcAcadian asset managementSecurities exchange commissionNektar therapeuticsCm managementJefferies financial groupGet free reportDeep track capitalExchange commissionTherapeutics trading downFinancial groupAsset managementNektar therapeutics daily

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share

Heron Therapeutics, Inc (NASDAQ:HRTX) Expected to Earn Q2 2024 Earnings of ($0 04) Per Share
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United statesNorthland capmkSusquehanna fundamental investmentsCommonwealth equity servicesHeron therapeutics incNeedham companyBoard of administration florida retirement systemHeadlands technologiesVictory capital management incHeron therapeuticsFree reportHeron therapeuticGet free reportOne financialTherapeutics trading downCapital management

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho

Axsome Therapeutics (NASDAQ:AXSM) Given New $106 00 Price Target at Mizuho
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRoger jeffsPiper sandlerMarkl jacobsonSecurities exchange commissionCovestor ltdRussell investments group ltdAxsome therapeutics incWashington trust advisors incCantor fitzgeraldFifth third bancorpThird bancorpChina universal asset management coRoyal bankAxsome therapeuticsFree report

Allogene Therapeutics, Inc (NASDAQ:ALLO) Given Consensus Recommendation of Moderate Buy by Analysts

Allogene Therapeutics, Inc (NASDAQ:ALLO) Given Consensus Recommendation of Moderate Buy by Analysts
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

Mirae asset global investments coSusquehanna fundamental investmentsHeadlands technologiesAllogene therapeutics incAllogene therapeutics company profileRoyal bankChina universal asset management coBourgeon capital managementJpmorgan chase coAllogene therapeuticsGet free reportMarketbeat ratingsTherapeutics trading downFundamental investmentsAsset global investmentsUniversal asset management

Denali Therapeutics Inc (NASDAQ:DNLI) Receives Average Recommendation of Moderate Buy from Analysts

Denali Therapeutics Inc (NASDAQ:DNLI) Receives Average Recommendation of Moderate Buy from Analysts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesNew zealand generalNew zealandVickil satoStevee krognesStifel nicolausGotham asset managementDenali therapeutics incWellington management groupEventide asset managementGoldman sachs groupSecurities exchange commissionCapital partnersDenali therapeuticsGet free reportMarketbeat ratings